...
首页> 外文期刊>Cell death & disease. >MicroRNA-22 inhibits tumor growth and metastasis in gastric cancer by directly targeting MMP14 and Snail
【24h】

MicroRNA-22 inhibits tumor growth and metastasis in gastric cancer by directly targeting MMP14 and Snail

机译:MicroRNA-22通过直接靶向MMP14和Snail抑制胃癌的肿瘤生长和转移

获取原文
   

获取外文期刊封面封底 >>

       

摘要

MicroRNAs (miRNAs) deregulation is frequent in human gastric cancers (GCs), but the role of specific miRNAs involved in this disease remains elusive. MiR-22 was previously reported to act as tumor suppressors or oncogenes in diverse cancers. However, their accurate expression, function and mechanism in GC are largely unclear. Here, we found that the expression of miR-22 was significantly reduced in clinical GC tissues compared with paired adjacent normal tissues, and was significantly correlated with a more aggressive phenotype of GC in patients, and miR-22 low expression correlated with poor overall survival. The introduction of miR-22 markedly suppressed GC cell growth, migration and invasion, and inhibition of miR-22 promoted GC cell proliferation, migration and invasion in vitro . We further demonstrated that miR-22 acted as tumor suppressors through targeting extracellular matrix (ECM) remodeling member matrix metalloproteinase 14 (MMP14) and epithelial-to-mesenchymal transition (EMT) inducer Snail in GC. Moreover, ectopic expression of MMP14 or Snail restored inhibitory effects of miR-22 on cell migration and invasion in GC cells, and a negative relationship between the miR-22 expression and MMP14 or Snail mRNA levels was observed in GC. Finally, overexpression of miR-22 suppressed tumor growth, peritoneal dissemination and pulmonary metastasis in vivo . Taken together, we identified that miR-22 is a potent tumor suppressor in GC. MiR-22 downregulation promotes GC invasion and metastasis by upregulating MMP14 and Snail, and then inducing ECM remodeling and EMT. These findings provide a better understanding of the development and progression of GC and may be an important implication for future therapy of the GC.
机译:MicroRNA(miRNA)的失控在人类胃癌(GC)中很常见,但是与这种疾病有关的特定miRNA的作用仍然难以捉摸。以前有报道说MiR-22在多种癌症中起着抑癌或致癌基因的作用。但是,它们在GC中的准确表达,功能和机制尚不清楚。在这里,我们发现与配对的正常组织相比,miR-22的表达在临床GC组织中显着降低,并且与患者中更具侵略性的GC表型显着相关,而miR-22的低表达与整体存活率低相关。 miR-22的引入显着抑制了GC细胞的生长,迁移和侵袭,而抑制miR-22则在体外促进了GC细胞的增殖,迁移和侵袭。我们进一步证明,miR-22通过靶向GC中的细胞外基质(ECM)重塑成员基质金属蛋白酶14(MMP14)和上皮-间质转化(EMT)诱导剂Snail发挥抑癌作用。此外,MMP14或Snail的异位表达恢复了miR-22对GC细胞中细胞迁移和侵袭的抑制作用,并且在GC中观察到miR-22表达与MMP14或Snail mRNA水平之间呈负相关。最后,miR-22的过表达抑制了体内肿瘤的生长,腹膜的扩散和肺转移。综上所述,我们确定miR-22在GC中是有效的肿瘤抑制因子。 MiR-22的下调通过上调MMP14和Snail,然后诱导ECM重塑和EMT来促进GC侵袭和转移。这些发现提供了对GC的发展和进展的更好理解,并且可能对GC的未来治疗具有重要意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号